Candelanza, Mylyn B.

HRN: 01-98-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2023
AMPICILLIN 1GM (VIAL)
07/09/2023
07/10/2023
IV
2g
Now Then Q6
PROM
Waiting Final Action 
07/09/2023
CEFUROXIME 500MG (TAB)
07/09/2023
07/15/2023
ORAL
500
BId
Rmle
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: